Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 4
2011 5
2012 7
2013 3
2014 3
2015 5
2016 10
2017 16
2018 9
2019 6
2020 4
2021 4
2022 6
2023 4
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Flibanserin.
Vallejos X, Wu C. Vallejos X, et al. J Pharm Pract. 2017 Apr;30(2):256-260. doi: 10.1177/0897190016630409. Epub 2016 Jul 9. J Pharm Pract. 2017. PMID: 26873507 Review.
DATA SOURCES: A literature search of PubMed using the key words flibanserin and HSDD was conducted in September 2015. There was no time frame to exclude relevant clinical trials. ...DATA SYNTHESIS: There are three 24-week, multicenter, randomized, double-blind, plac …
DATA SOURCES: A literature search of PubMed using the key words flibanserin and HSDD was conducted in September 2015. There wa …
Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
Simon JA, Kingsberg SA, Goldstein I, Kim NN, Hakim B, Millheiser L. Simon JA, et al. Sex Med Rev. 2019 Oct;7(4):575-586. doi: 10.1016/j.sxmr.2019.04.003. Epub 2019 Jun 10. Sex Med Rev. 2019. PMID: 31196764 Review.
RESULTS: Based on flibanserin clinical trial data, there was no consistent correlation between weight loss and improvement in sexual function, as assessed by HSDD outcome measures. ...Future research may better elucidate the links between sexual function and weight …
RESULTS: Based on flibanserin clinical trial data, there was no consistent correlation between weight loss and improvement in sexual …
Flibanserin.
Pierrelus C, Patel P, Carlson K. Pierrelus C, et al. 2023 Nov 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Nov 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36943967 Free Books & Documents.
This makes flibanserin a pivotal choice for premenopausal women experiencing primary HSDD. This activity covers flibanserin's indications, contraindications, mechanism of action, administration, monitoring, and toxicity. This activity aims to enhance collabor …
This makes flibanserin a pivotal choice for premenopausal women experiencing primary HSDD. This activity covers flibanserin …
Flibanserin and its discontents.
Aftab A, Chen C, McBride J. Aftab A, et al. Arch Womens Ment Health. 2017 Apr;20(2):243-247. doi: 10.1007/s00737-016-0693-6. Epub 2016 Nov 17. Arch Womens Ment Health. 2017. PMID: 27858170 Review.
In August 2015, flibanserin (brand name Addyi) was approved by the Food and Drug Administration (FDA) for treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. This article summarizes and promotes discussion regarding th …
In August 2015, flibanserin (brand name Addyi) was approved by the Food and Drug Administration (FDA) for treatment of acquired, gene …
Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.
Pettigrew JA, Novick AM. Pettigrew JA, et al. J Midwifery Womens Health. 2021 Nov;66(6):740-748. doi: 10.1111/jmwh.13283. Epub 2021 Sep 12. J Midwifery Womens Health. 2021. PMID: 34510696 Free PMC article. Review.
This is an up-to-date overview of HSDD for clinicians, discussing its physiology, assessment, diagnosis, and treatment strategies. ...The 2 recently approved medications for HSDD, flibanserin and bremelanotide, are reviewed as well as off-label treatments. Ov …
This is an up-to-date overview of HSDD for clinicians, discussing its physiology, assessment, diagnosis, and treatment strategies. .. …
Medical Treatment of Female Sexual Dysfunction.
Nappi RE, Tiranini L, Martini E, Bosoni D, Righi A, Cucinella L. Nappi RE, et al. Urol Clin North Am. 2022 May;49(2):299-307. doi: 10.1016/j.ucl.2022.02.001. Urol Clin North Am. 2022. PMID: 35428435 Review.
The therapeutic algorithm comprises a multidisciplinary approach, including pharmacologic and nonpharmacologic management. Flibanserin and bremelanotide are psychoactive agents indicated for the treatment of generalized acquired hypoactive sexual desire disorder (HSDD …
The therapeutic algorithm comprises a multidisciplinary approach, including pharmacologic and nonpharmacologic management. Flibanserin …
Evaluation of safety for flibanserin.
Clayton AH, Brown L, Kim NN. Clayton AH, et al. Expert Opin Drug Saf. 2020 Jan;19(1):1-8. doi: 10.1080/14740338.2020.1707804. Epub 2019 Dec 23. Expert Opin Drug Saf. 2020. PMID: 31855607 Review.
Indicated for premenopausal women, flibanserin is the first FDA-approved medication to treat HSDD.Areas covered: This review summarizes flibanserin's pharmacokinetics, proposed mechanism of action, and safety data in clinical trials with a focus on sedation- …
Indicated for premenopausal women, flibanserin is the first FDA-approved medication to treat HSDD.Areas covered: This review s …
Flibanserin: First Global Approval.
Deeks ED. Deeks ED. Drugs. 2015 Oct;75(15):1815-22. doi: 10.1007/s40265-015-0474-y. Drugs. 2015. PMID: 26412054 Review.
Flibanserin has been approved in the USA for the treatment of premenopausal women with acquired, generalized HSDD. ...This article summarizes the milestones in the development of flibanserin leading to its first approval for HSDD....
Flibanserin has been approved in the USA for the treatment of premenopausal women with acquired, generalized HSDD. ...This art …
Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Dhanuka I, Simon JA. Dhanuka I, et al. Expert Opin Pharmacother. 2015;16(16):2523-9. doi: 10.1517/14656566.2015.1090426. Epub 2015 Sep 22. Expert Opin Pharmacother. 2015. PMID: 26395164 Review.
AREAS COVERED: Flibanserin, a multifunctional serotonin agonist/antagonist, is approved as a nonhormonal option designed specifically for the treatment of HSDD. ...EXPERT OPINION: While there has been debate over the approval of flibanserin for treatment of …
AREAS COVERED: Flibanserin, a multifunctional serotonin agonist/antagonist, is approved as a nonhormonal option designed specifically …
Flibanserin - the female Viagra?
Shapiro D, Stevens D, Stahl SM. Shapiro D, et al. Int J Psychiatry Clin Pract. 2017 Nov;21(4):259-265. doi: 10.1080/13651501.2017.1315138. Epub 2017 Apr 24. Int J Psychiatry Clin Pract. 2017. PMID: 28434386 Review.
This article provides a clinically relevant review of the first medication approved by the US Food and Drug Administration for hypoactive sexual desire disorder (HSDD) in premenopausal women. In this short piece, the human sexual response cycle and its relevance to HSDD …
This article provides a clinically relevant review of the first medication approved by the US Food and Drug Administration for hypoactive se …
75 results